Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

Cited In for PubMed (Select 15781642)

1.

Naturally occurring anthraquinones: chemistry and therapeutic potential in autoimmune diabetes.

Chien SC, Wu YC, Chen ZW, Yang WC.

Evid Based Complement Alternat Med. 2015;2015:357357. doi: 10.1155/2015/357357. Epub 2015 Mar 18. Review.

2.

Synthesis of an anthraquinone derivative (DHAQC) and its effect on induction of G2/M arrest and apoptosis in breast cancer MCF-7 cell line.

Yeap S, Akhtar MN, Lim KL, Abu N, Ho WY, Zareen S, Roohani K, Ky H, Tan SW, Lajis N, Alitheen NB.

Drug Des Devel Ther. 2015 Feb 17;9:983-92. doi: 10.2147/DDDT.S65468. eCollection 2015.

3.

Pharmacologic down-regulation of EZH2 suppresses bladder cancer in vitro and in vivo.

Tang SH, Huang HS, Wu HU, Tsai YT, Chuang MJ, Yu CP, Huang SM, Sun GH, Chang SY, Hsiao PW, Yu DS, Cha TL.

Oncotarget. 2014 Nov 15;5(21):10342-55.

4.

The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.

Bishop JL, Thaper D, Zoubeidi A.

Cancers (Basel). 2014 Apr 9;6(2):829-59. doi: 10.3390/cancers6020829.

5.

Pterostilbene-isothiocyanate conjugate suppresses growth of prostate cancer cells irrespective of androgen receptor status.

Nikhil K, Sharan S, Chakraborty A, Roy P.

PLoS One. 2014 Apr 3;9(4):e93335. doi: 10.1371/journal.pone.0093335. eCollection 2014.

6.

A naturally derived small molecule disrupts ligand-dependent and ligand-independent androgen receptor signaling in human prostate cancer cells.

Amin KS, Jagadeesh S, Baishya G, Rao PG, Barua NC, Bhattacharya S, Banerjee PP.

Mol Cancer Ther. 2014 Feb;13(2):341-52. doi: 10.1158/1535-7163.MCT-13-0478. Epub 2013 Nov 20.

7.

Emodin induces apoptosis of human cervical cancer hela cells via intrinsic mitochondrial and extrinsic death receptor pathway.

Yaoxian W, Hui Y, Yunyan Z, Yanqin L, Xin G, Xiaoke W.

Cancer Cell Int. 2013 Jul 16;13(1):71. doi: 10.1186/1475-2867-13-71.

8.

Emodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ER α Inhibition.

Huang PH, Huang CY, Chen MC, Lee YT, Yue CH, Wang HY, Lin H.

Evid Based Complement Alternat Med. 2013;2013:376123. doi: 10.1155/2013/376123. Epub 2013 Jun 24.

9.

HMGB1: A Promising Therapeutic Target for Prostate Cancer.

Gnanasekar M, Kalyanasundaram R, Zheng G, Chen A, Bosland MC, Kajdacsy-Balla A.

Prostate Cancer. 2013;2013:157103. doi: 10.1155/2013/157103. Epub 2013 May 12.

10.

Emodin regulates glucose utilization by activating AMP-activated protein kinase.

Song P, Kim JH, Ghim J, Yoon JH, Lee A, Kwon Y, Hyun H, Moon HY, Choi HS, Berggren PO, Suh PG, Ryu SH.

J Biol Chem. 2013 Feb 22;288(8):5732-42. doi: 10.1074/jbc.M112.441477. Epub 2013 Jan 9.

11.

Emodin as an effective agent in targeting cancer stem-like side population cells of gallbladder carcinoma.

Li XX, Dong Y, Wang W, Wang HL, Chen YY, Shi GY, Yi J, Wang J.

Stem Cells Dev. 2013 Feb 15;22(4):554-66. doi: 10.1089/scd.2011.0709. Epub 2012 Nov 7.

12.

20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor.

Cao B, Liu X, Li J, Liu S, Qi Y, Xiong Z, Zhang A, Wiese T, Fu X, Gu J, Rennie PS, Sartor O, Lee BR, Ip C, Zhao L, Zhang H, Dong Y.

Int J Cancer. 2013 Mar 15;132(6):1277-87. doi: 10.1002/ijc.27754. Epub 2012 Aug 20.

13.

Catenarin Prevents Type 1 Diabetes in Nonobese Diabetic Mice via Inhibition of Leukocyte Migration Involving the MEK6/p38 and MEK7/JNK Pathways.

Shen MY, Lin YP, Yang BC, Jang YS, Chiang CK, Mettling C, Chen ZW, Sheu JR, Chang CL, Lin YL, Yang WC.

Evid Based Complement Alternat Med. 2012;2012:982396. doi: 10.1155/2012/982396. Epub 2012 Feb 13.

14.

Combined phytochemistry and chemotaxis assays for identification and mechanistic analysis of anti-inflammatory phytochemicals in Fallopia japonica.

Shen MY, Liu YJ, Don MJ, Liu HY, Chen ZW, Mettling C, Corbeau P, Chiang CK, Jang YS, Li TH, Young P, Chang CL, Lin YL, Yang WC.

PLoS One. 2011;6(11):e27480. doi: 10.1371/journal.pone.0027480. Epub 2011 Nov 8. Erratum in: PLoS One. 2012;7(6). doi:10.1371/annotation/e81927cf-e940-4604-acfa-44b5655e40a3.

15.

The Apoptotic Effect of the Hexane Extract of Rheum undulatum L. in Oral Cancer Cells through the Down-regulation of Specificity Protein 1 and Survivin.

Choi ES, Cho SD, Jeon JG, Cho NP.

Lab Anim Res. 2011 Mar;27(1):19-24. doi: 10.5625/lar.2011.27.1.19. Epub 2011 Mar 25.

16.

Anti-cancer natural products isolated from chinese medicinal herbs.

Tan W, Lu J, Huang M, Li Y, Chen M, Wu G, Gong J, Zhong Z, Xu Z, Dang Y, Guo J, Chen X, Wang Y.

Chin Med. 2011 Jul 22;6(1):27. doi: 10.1186/1749-8546-6-27.

17.

G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.

Liu J, Youn H, Yang J, Du N, Liu J, Liu H, Li B.

Prostate. 2011 Sep;71(12):1276-86. doi: 10.1002/pros.21345. Epub 2011 Feb 9.

18.

Preferential induction of G1 arrest in androgen-responsive human prostate cancer cells by androgen receptor signaling antagonists DL3 and antiandrogen bicalutamide.

Lu S, Tan Z, Wortman M, Lu S, Dong Z.

Cancer Lett. 2010 Dec 8;298(2):250-7. doi: 10.1016/j.canlet.2010.07.012. Epub 2010 Aug 2.

19.

Species and gender differences affect the metabolism of emodin via glucuronidation.

Liu W, Tang L, Ye L, Cai Z, Xia B, Zhang J, Hu M, Liu Z.

AAPS J. 2010 Sep;12(3):424-36. doi: 10.1208/s12248-010-9200-6. Epub 2010 May 14.

20.

MUC1 oncoprotein is a druggable target in human prostate cancer cells.

Joshi MD, Ahmad R, Yin L, Raina D, Rajabi H, Bubley G, Kharbanda S, Kufe D.

Mol Cancer Ther. 2009 Nov;8(11):3056-65. doi: 10.1158/1535-7163.MCT-09-0646. Epub 2009 Nov 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk